Age Not a Deterrent to Immunotherapy for Malignant Melanoma – Oncology Nurse Advisor
Oncology Nurse Advisor |
Age Not a Deterrent to Immunotherapy for Malignant Melanoma
Oncology Nurse Advisor Patients >65 years of age with metastatic melanoma who are treated with immunotherapy do not have an increased risk for immune-related adverse events (AEs), according to the results of a recent single-center, retrospective cohort study published in … |
